Michael Gottschalk - Concepedia

Author

Michael Gottschalk

University of California San Diego ORCID

Also Known As

Brenda Thurlow, Chantal Nwosu, M E Gottschalk, M Gottschalk, M. Gottschalk, M. Hashiguchi, M.E. Gottschalk, MICHAEL GOTTSCHALK, Michael E Gottschalk, Michael E. Gottschalk

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

University of California San Diego Rady Children's Hospital-San Diego University of Tübingen University of Colorado Anschutz Medical Campus Yale University

About

Michael Gottschalk is an author at University of California San Diego specializing in medicine, diabetes, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	1.8K
2	Engineering	4	4	472
3	Health Sciences	4	4	252
4	Public Health	4	4	342
5	Natural Sciences	3	3	104

Michael Gottschalk

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
The PedsQL™ in Type 1 and Type 2 Diabetes James W. Varni, Tasha M. Burwinkle, Jenifer R. Jacobs, Diabetes Care	2003	582
Resistance to Thyrotropin Caused by Mutations in the Thyrotropin-Receptor Gene T Sunthornthepvarakul, Michael Gottschalk, Yoshitaka Hayashi, New England Journal of Medicine Thyroid Hormone ExcessEngineeringGeneticsMolecular GeneticsHormone Receptors	1995	347
Preparing Adolescents With Chronic Disease for Transition to Adult Care: A Technology Program Jeannie S. Huang, Laura Terrones, Trevor Tompane, PEDIATRICS	2014	216
A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin David G. Alleva, Paul D. Crowe, Liping Jin, Journal of Clinical Investigation Insulin B ChainImmunologyImmune RegulationPathologyDominant Epitope	2001	210
Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States Stephanie N. DuBose, Julia M. Hermann, William V. Tamborlane, The Journal of Pediatrics ObesityMetabolic SyndromeType 1Childhood ObesityHealth Policy	2015	177
Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency Nils Krone, Nicole Reisch, Jan Idkowiak, The Journal of Clinical Endocrinology & Metabolism	2011	163
Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial Stephen E. Gitelman, Peter A. Gottlieb, Mark Rigby, The Lancet Diabetes & Endocrinology Diabetes ManagementDiabetesDiabetes MellitusAntithymocyte Globulin TreatmentMedicine	2013	142
Glimepiride Versus Metformin as Monotherapy in Pediatric Patients With Type 2 Diabetes Michael Gottschalk, Thomas Danne, Aleksandra Vlajnic, Diabetes Care	2007	141
Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia Young Hee Lim, Diana Ovejero, Jeffrey Sugarman, Human Molecular Genetics SclerostinSomatic VariantSkin TissueBone Morphogenic ProteinGenetic Disorder	2013	133
The Diagnosis of Congenital Adrenal Hyperplasia in the Newborn by Gas Chromatography/Mass Spectrometry Analysis of Random Urine Specimens Michael P. Caulfield, Thomas C. Lynn, Michael Gottschalk, The Journal of Clinical Endocrinology & Metabolism	2002	110

Page 1